EANS-News: Hypoport-subsidiary Dr. Klein presents good figures and new solutions in talks during the EXPO REAL 2009

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Financial Figures/Balance Sheet/Company Information

Berlin, (euro adhoc) - 5 October 2009: Dr. Klein is clearly setting
itself apart from its competitors in the marketplace with a growth
rate in excess of 30 percent for all financing transaction
settlements over the last 12 months. The volume in the most
important sub-segment - long-term new business - even increased by
75 percent. The good figures are the result of the in-depth
understanding of the sector that the financial services provider
has been building since 1954, combined with its ability to
flexibly adapt to new market conditions. The developments of
the market leader will be addressed in more detail during a
theme discussion at the EXPO REAL.

The total volume of financing transactions arranged by Dr. Klein
increased by 30 percent over the last twelve months from EUR 1,332
million (Q4/2007-Q3/2008) to their current level of EUR 1,750 million
(Q4/2008-Q3/2009). The 75 percent increase from EUR 800 million to
EUR 1,408 million in long-term new business - the most important
sub-segment - is an even better reflection of this positive
development.

Good reasons for good figures Dr. Klein has clearly distanced itself
from the general developments in the marketplace - since the
financial crisis started gaining in intensity a year ago. Hans
Peter Trampe, responsible member of the management board,
attributes these good figures to a number of reasons. Potential
borrowers are still finding it difficult to identify who is
nowadays willing to lend money. Thanks to its extensive network and
the relationships of trust that the market leader has built up over
the years to potential lenders, Dr. Klein can provide its
clients with the necessary information. Creating this market
transparency is, however, just one of the important success factors.
Impartial advisory services that help clients, among other things,
to optimise their interest rate and collateral structures also
contributed to the positive result. In Trampe's opinion, these
services, in particular, are an absolutely crucial aspect of
addressing the demand for financing products, given the marked
increase in margins at high loan to value ratios.

New solutions for new market conditions The news from the financial
products marketplace is, however, not all negative: "Many insurance
companies and pension funds are discovering the benefits of the real
estate sector as a comparatively low-risk asset class. And some
banks who scorned the tight margins offered by such business in the
past are now learning to appreciate the solid strength of the
sector", is how Trampe describes the current market situation.
Dr. Klein offers innovative solutions to these new market
players: According to Trampe: "Bearer bonds issued by the borrowers
even enable us to service lenders who are not actually allowed to
engage in credit business themselves".

Success also extends to large-scale financing transactions Over the
past 12 months, Dr. Klein has been particularly successful
in financing large deals. "The market is particularly narrow at this
end. The "why not take a bit more?" attitude of former times has now
been replaced with "the more you want the more it costs". Only
very few lenders are capable of financing 50 million Euros or
even more without difficulties. Dr. Klein therefore compiles
syndicates to arrange the financing of large deals, but without
binding the individual lenders to each other as is often the case
with classic bank syndicates. The dependency on a syndicate or the
lead manager of the same is eliminated, thus giving the borrower
much more independence than would be the case with a classic
syndicate management structure.

Discussion at the EXPO REAL 2009 Trampe will provide more detailed
explanations with special focus on the new solutions at the EXPO
REAL. He will be addressing new financing approaches and
opportunities in the theme discussion with journalist and presenter
Miriam Beul on Monday, 5 October 2009. The discussion entitled "How
are major real estate deals financed nowadays? New approaches, new
opportunities!" will take place at the BSI booth, Hall B2, Booth 220
on Monday, starting at 3:30 p.m.

+ + + Die Dr. Klein & Co. AG, a wholly owned subsidiary of Hypoport
AG, which is listed in the Prime Standard, can be found in Hall B2 at
Booth 220 at the EXPO REAL. + + +

About Dr. Klein The Corporate Clients business unit at Dr. Klein &
Co. AG was set up in 1954 to develop provider-neutral financing and
insurance solutions for companies and municipalities. The German
residential industry constitutes the largest client group; Dr.
Klein leads the market for arranging loans in this sector. The range
of offered services encompasses the organisation of low-cost
loans and the provision of advice on optimising financing
structures, right up to the development of customised insurance
solutions. In providing these services, Dr. Klein makes the best use
of its network consisting of a large number of banks, insurance
companies and pension funds. Our clients benefit from the
synergies within Hypoport Group, for example when using the
EUROPACE-WoWi portfolio management system or when procuring
bank-neutral financing on the capital market. In doing so, assets
valued far in excess of one billion Euros are re- financed and
insured each year. Regardless of whether private clients are
looking for current accounts, call money, insurance policies,
financial investments, mortgage financing or private loans, Dr.
Klein can provide them with just the right product to meet their
individual requirements.

Ende der Mitteilung euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Hypoport AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Michaela Reimann

Group Communications Manager

Telefon: +49(0)30 42086-1936

E-Mail: michaela.reimann@hypoport.de

Branche: Financial & Business Services
ISIN: DE0005493365
WKN: 549336
Börsen: Frankfurt / regulated dealing/prime standard